Accelerate to discover
Related topics
IncuCyte webinar: high throughput approach to developing T- Cell immunotherapies
Jun 17, 2019
Immunotherapy for cancers involves artificially prompting the immune system to treat cancer. Many cancer cells have...
IncuCyte virtual event: Dimension of time - from culture to assay
Jun 5, 2019
This event offers an overview of how live-cell analysis enables real-time analysis for the full workflow of the cells....
Webinar recording: Detecting cancer-associated structural variants using Bionano optical maps
May 15, 2019
Bionano’s genome mapping technology directly observes long molecules from 150,000 bp to megabase pair lengths to...
IncuCyte webinar recording: Human Neurons in vitro, next-gen models for neurological disease
Apr 23, 2019
The ability to generate and manipulate human neurons in vitro is an exciting advance that enables the validation,...
Rapid, Quantitative CEST Imaging with MRI Fingerprinting
Apr 16, 2019
With applications spanning almost any disease area, from cancer, stroke, through to cardiac metabolism disorders, this...
Monitoring cancer treatments with immuno-PET webinar
Mar 8, 2019
In this webinar, Dr Gabriela Kramer-Marek, Team Leader in Preclinical Molecular Imaging The Institute of Cancer...
Spectral data analysis webinar recording - Cytek flow cytometer and De Novo Software
Jan 17, 2019
Cytek Biosciences and De Novo Software are proud to announce a collaboration that allows you to work with your spectral...
IncuCyte webinar recording: CAR T-cell therapy, frontiers in cancer Immunotherapy
Jan 11, 2019
The success of immune checkpoint blockade adds new therapeutic category to Cancers are the most heterogenous group of...
Oct 13, 2016
Nabil Ahmed, M.D., M.P.H. Associate Professor of Pediatrics, Baylor College of Medicine (USA).
Robust CAR design and sensitive yet realistic functional testing will be required in order to improve the efficacy of CAR T cell therapies targeting solid tumors. We have used the xCELLigence Real-Time Cell Analyzer as a high-throughput platform to test multiple CAR components including extracellular domains (including bi-specifics), signaling endo-domains, as well as next-generation CAR T cell products that are inherently resistant to checkpoint blockade. This platform has proven very sensitive to subtle yet longitudinally meaningful differences in CAR design, and has made it possible to evaluate T cell products in a "stress test" that is more representative of early phase trial requirements.
Related technologies: Real-time, label free cell analysis
Get more info
Brand profile
ACEA manufactures xCELLigence impedance-based, label-free, real time cell analysis system and NovoCyte flow cytometers.
More info at:
www.aceabio.com
BioFocus newsletter
Register to receive Brand new technology development, Important product updates, Interesting scientific events and more!
BioTech a.s. © 2014
Designed & developed by imagineit
Technologies
